Participants in TCA Cellular Therapy’s Stem Cell Protocol Experiencing Remarkable Results

COVINGTON, La.--(BUSINESS WIRE)--Participants in a Federal Drug Administration (FDA) protocol at TCA Cellular Therapy utilizing stem cells to treat lower limb ischemia are experiencing increased mobility and decreased pain in lower legs.